Life Science Leader Magazine

DEC 2013

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/216720

Contents of this Issue

Navigation

Page 50 of 51

Gallus Acquires Laureate Shaun, Principal Scientist, Cell Culture Development Synergy Expands Unique Flexibility Gallus adds further flexibility to its CMO services with the acquisition of Laureate. We've doubled our biologics clinical development capacity by adding a complementary FDA-approved cGMP facility in Princeton, New Jersey. Clinical and commercial supply capabilities have expanded and include flexible and fixed stainless steel up to 2,000 L and single-use HyClone™, WAVE™ and Xcellerex™ technologies up to 2,000 L, in addition to clinical aseptic fill-finish capabilities. We continue to offer our pioneering and flexible approach, including the SuiteSPACE® virtual ownership model. Contact Gallus to learn how far we'll go to work for you. info@gallusbiopharma.com | www.gallusbiopharma.com Uniquely Flexible CMO™ WINNER REGULATORY PRODUCTIVITY SuiteSPACE is a registered trademark of Gallus BioPharmaceuticals. WAVE and Xcellerex are trademarks of GE and HyClone is a trademark of Thermo Fisher Scientific. © Copyright 2013 Gallus BioPharmaceuticals, LLC. All rights reserved.

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine - DEC 2013